These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
221 related items for PubMed ID: 30407519
1. Change in Bacterial Causes of Community-Acquired Parapneumonic Effusion and Pleural Empyema in Children 6 Years After 13-Valent Pneumococcal Conjugate Vaccine Implementation. Madhi F, Levy C, Morin L, Minodier P, Dubos F, Zenkhri F, Dommergues MA, Mezgueldi E, Levieux K, Pneumonia Study Group
, Béchet S, Varon E, Cohen R, GPIP (Pediatric Infectious Disease Group)
. J Pediatric Infect Dis Soc; 2019 Nov 06; 8(5):474-477. PubMed ID: 30407519 [Abstract] [Full Text] [Related]
2. Characteristics of Streptococcus pyogenes Versus Streptococcus pneumoniae Pleural Empyema and Pneumonia With Pleural Effusion in Children. Megged O. Pediatr Infect Dis J; 2020 Sep 06; 39(9):799-802. PubMed ID: 32804461 [Abstract] [Full Text] [Related]
3. Changes in the incidence and bacterial aetiology of paediatric parapneumonic pleural effusions/empyema in Germany, 2010-2017: a nationwide surveillance study. Liese JG, Schoen C, van der Linden M, Lehmann L, Goettler D, Keller S, Maier A, Segerer F, Rose MA, Streng A. Clin Microbiol Infect; 2019 Jul 06; 25(7):857-864. PubMed ID: 30395932 [Abstract] [Full Text] [Related]
4. Early impact of 13-valent pneumococcal conjugate vaccine on community-acquired pneumonia in children. Angoulvant F, Levy C, Grimprel E, Varon E, Lorrot M, Biscardi S, Minodier P, Dommergues MA, Hees L, Gillet Y, Craiu I, Zenkhri F, Dubos F, Guen CG, Launay E, Martinot A, Cohen R. Clin Infect Dis; 2014 Apr 06; 58(7):918-24. PubMed ID: 24532543 [Abstract] [Full Text] [Related]
5. Pneumonia with empyema among children in the first five years of high coverage with 13-valent pneumococcal conjugate vaccine. Syrogiannopoulos GA, Michoula AN, Tsimitselis G, Vassiou K, Chryssanthopoulou DC, Grivea IN. Infect Dis (Lond); 2016 Oct 06; 48(10):749-53. PubMed ID: 27320108 [Abstract] [Full Text] [Related]
6. Increase in Streptococcus pneumoniae serotype 3 associated parapneumonic pleural effusion/empyema after the introduction of PCV13 in Germany. Goettler D, Streng A, Kemmling D, Schoen C, von Kries R, Rose MA, van der Linden M, Liese JG. Vaccine; 2020 Jan 16; 38(3):570-577. PubMed ID: 31735502 [Abstract] [Full Text] [Related]
7. A case report of parapneumonic pleural effusion caused by Streptococcus pneumoniae serotype 19A in a child immunized with 13-valent conjugate pneumococcal vaccine. Diawara I, Zerouali K, Elmdaghri N, Abid A. BMC Pediatr; 2017 Apr 27; 17(1):114. PubMed ID: 28449653 [Abstract] [Full Text] [Related]
8. Complicated pneumococcal pneumonia with pleural effusion or empyema in the 13-valent pneumococcal conjugate vaccine era. Díaz-Conradi A, Hernández S, García-García JJ, Muñoz-Almagro C, Moraga-Llop F, Ciruela P, Izquierdo C, Campins M, de Sevilla MF, González-Peris S, Uriona S, Martínez-Osorio J, Solé-Ribalta A, Codina G, Esteva C, Planes AM, Soldevila N, Salleras L, Domínguez A. Pediatr Pulmonol; 2019 May 27; 54(5):517-524. PubMed ID: 30784235 [Abstract] [Full Text] [Related]
9. Etiology of parapneumonic effusion and pleural empyema in children. The role of conventional and molecular microbiological tests. Krenke K, Sadowy E, Podsiadły E, Hryniewicz W, Demkow U, Kulus M. Respir Med; 2016 Jul 27; 116():28-33. PubMed ID: 27296817 [Abstract] [Full Text] [Related]
10. A multicenter study on the epidemiology of complicated parapneumonic effusion in the era of currently available pneumococcal conjugate vaccines. Papachristidou S, Lapea V, Charisi M, Kourkouni E, Kousi D, Xirogianni A, Dedousi O, Papaconstadopoulos I, Eleftheriou E, Krepis P, Pasparaki S, Pantalos G, Doudoulakakis A, Bozavoutoglou E, Daskalaki M, Kostaridou-Nikolopoulou S, Tzanakaki G, Spoulou V, Tsolia M. Vaccine; 2023 Oct 26; 41(45):6727-6733. PubMed ID: 37805358 [Abstract] [Full Text] [Related]
15. Etiology and Incidence of Pleural Empyema in South African Children. Zampoli M, Kappos A, Wolter N, von Gottberg A, Verwey C, Mamathuba R, Zar HJ. Pediatr Infect Dis J; 2015 Dec 26; 34(12):1305-10. PubMed ID: 26267310 [Abstract] [Full Text] [Related]
16. Five-fold increase in pediatric parapneumonic empyema since introduction of pneumococcal conjugate vaccine. Hendrickson DJ, Blumberg DA, Joad JP, Jhawar S, McDonald RJ. Pediatr Infect Dis J; 2008 Nov 26; 27(11):1030-2. PubMed ID: 18845981 [Abstract] [Full Text] [Related]
17. Long-term Association of 13-Valent Pneumococcal Conjugate Vaccine Implementation With Rates of Community-Acquired Pneumonia in Children. Ouldali N, Levy C, Minodier P, Morin L, Biscardi S, Aurel M, Dubos F, Dommergues MA, Mezgueldi E, Levieux K, Madhi F, Hees L, Craiu I, Gras Le Guen C, Launay E, Zenkhri F, Lorrot M, Gillet Y, Béchet S, Hau I, Martinot A, Varon E, Angoulvant F, Cohen R. JAMA Pediatr; 2019 Apr 01; 173(4):362-370. PubMed ID: 30715140 [Abstract] [Full Text] [Related]
18. Childhood empyema: limited potential impact of 7-valent pneumococcal conjugate vaccine. Fletcher M, Leeming J, Cartwright K, Finn A, South West of England Invasive Community Acquired Infection Study Group. Pediatr Infect Dis J; 2006 Jun 01; 25(6):559-60. PubMed ID: 16732158 [Abstract] [Full Text] [Related]
19. Pediatric parapneumonic effusion before and after national pneumococcal vaccination programs in Taiwan. Sim JY, Chang LY, Chang TH, Chen JM, Lee PI, Huang LM, Lu CY. J Formos Med Assoc; 2020 Nov 01; 119(11):1608-1618. PubMed ID: 32747171 [Abstract] [Full Text] [Related]